Business Bites: Elekta expands into Poland; Endo selling off AMS?
This article was originally published in Clinica
Swedish radiotherapy specialist Elekta is moving east, agreeing to acquire Polish distributor RTA for an undisclosed fee. It should be a growing market: Elekta expects cancer in Poland to increase almost 19% between 2012 and 2025, but the country isn’t equipped to deal with this growth. Poland currently has around 100 linear accelerators (linacs), used to deliver radiotherapy, but the optimal number is nearly 200, Elekta said, citing research published in Lancet Oncology.